FIELD: medicine. SUBSTANCE: method involves administering 50 ml of 0.5% sulfuric acid solution to be ingested by a patient 40-60 min before examination. 1 ml of 0.05% Proserinum solution or secretin or pancreozymin solution are injected subcutaneously or intravenously at a dose of 1 mg per 1 kg of body weight, respectively. The Wirsung's duct is visualized. EFFECT: reduced adverse side effects.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD TO PREDICT ATROPHIC PANCREATITIS IN PATIENTS WITH DUODENAL ULCER | 1999 |
|
RU2178987C2 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF PANCREATIC CANCER AND CHRONIC PANCREATITIS | 2009 |
|
RU2421149C2 |
| METHOD FOR DIAGNOSING THE CASES OF CHRONIC PANCREATITIS AGGRAVATED WITH DUODENAL PEPTIC ULCER | 1999 |
|
RU2178180C2 |
| METHOD FOR TREATMENT OF ACUTE CONDITION OF CHRONIC PANCREATITIS | 1999 |
|
RU2164154C2 |
| METHOD FOR PREDICTING EXACERBATION OF CHRONIC PANCREATITIS DEVELOPED AT THE BACKGROUND OF ULCEROUS DUODENAL DISEASE | 1999 |
|
RU2217763C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PANCREATIC CANCER AND CHRONIC PANCREATITIS | 2018 |
|
RU2714595C1 |
| METHOD FOR CARBOHYDRATE STATUS PREDICTION IN PATIENTS WITH PANCREATODUODENAL PATHOLOGY ASSOCIATING VARIOUS DUODENAL INVOLVEMENTS | 2010 |
|
RU2430681C1 |
| PANCREATIC CANCER AND CHRONIC PANCREATITIS DIFFERENTIAL DIAGNOSTIC TECHNIQUE | 2007 |
|
RU2353301C2 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR HEPATIC STEATOSIS AND STEATOHEPATITIS | 2013 |
|
RU2545990C2 |
| METHOD FOR DIAGNOSING CHRONIC PANCREATITIS CASES DEVELOPED ON THE BACKGROUND OF DUODENAL PEPTIC ULCER DISEASE | 2002 |
|
RU2249433C2 |
